Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
others source from compounding pharmacies or other supply chains COA availability and documentation standards vary by vendor Community sources describe the vendor channel as the most common procurement route for peptide research-context use
Athira Pharma's fosgonimeton (ATH-1017) targets the same HGF/c-Met program but is structurally distinct (sources conflict on whether it is a prodrug of Dihexa or a separate molecule)
A study looking for patterns about types of authors involved in retractions (all reasons), suggested that Early Career Researchers were particularly likely to be involved in retractions (Fanelli, Costas & Larivire, 2015), although the exact reason why remains obscure
Early studies on Gly-His-Lys (GHK), first discovered in human plasma in the 1970s, demonstrated their ability to modulate gene expression, stimulate collagen synthesis, and accelerate wound healing, sparking broad interest in these bioactive molecules [23]
US$ 28.84
US$ 20.43
US$ 25.84
US$ 22.80
US$ 26.55
US$ 29.38
US$ 25.79
